In vitro immune modulation by antibodies coupled to tumour cells.
Modification of autologous tumour cells to express the immune costimulator B7.1 is a potential strategy for immunotherapy of cancer. Previously, this has involved introduction of genetic material into cells, in vitro culture, and confirmation of the protein product on the cell surface. This is possi...
Những tác giả chính: | Darling, D, Galea-Lauri, J, Gäken, J, Towner, P, Kuiper, M, Hollingsworth, S, Hirst, W, Barnard, A, Buggins, A, Mufti, G, Farzaneh, F |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1997
|
Những quyển sách tương tự
-
Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells
Bằng: Gaken, J, et al.
Được phát hành: (1997) -
Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
Bằng: Hirst, W, et al.
Được phát hành: (1996) -
Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
Bằng: Gaken, J, et al.
Được phát hành: (1997) -
Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
Bằng: GaleaLauri, J, et al.
Được phát hành: (1996) -
An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Bằng: Chan, L, et al.
Được phát hành: (2006)